Szklener, K., Chmiel, P., Michalski, A., & Mańdziuk, S. (2022). New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors. Cancers, 14(6), 1416. https://doi.org/10.3390/cancers14061416
Chicago Style (17th ed.) CitationSzklener, Katarzyna, Paulina Chmiel, Adam Michalski, and Sławomir Mańdziuk. "New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors." Cancers 14, no. 6 (2022): 1416. https://doi.org/10.3390/cancers14061416.
MLA (9th ed.) CitationSzklener, Katarzyna, et al. "New Directions and Challenges in Targeted Therapies of Advanced Bladder Cancer: The Role of FGFR Inhibitors." Cancers, vol. 14, no. 6, 2022, p. 1416, https://doi.org/10.3390/cancers14061416.